sb 202190 has been researched along with Epithelial Ovarian Cancer in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicotine treatment reduced SKOV3 and TOV112D spheroid invasion and compaction but did not significantly affect spheroid formation." | 1.56 | Nicotine inhibits MAPK signaling and spheroid invasion in ovarian cancer cells. ( Bouni, ME; Chadee, DN; Harmych, SJ; Kumar, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harmych, SJ | 1 |
| Kumar, J | 1 |
| Bouni, ME | 1 |
| Chadee, DN | 1 |
1 other study available for sb 202190 and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Nicotine inhibits MAPK signaling and spheroid invasion in ovarian cancer cells.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Female; Humans; Imidazoles; Nic | 2020 |